KOP vs KRO

KOP presents a conflicting profile: it is fundamentally stable but lacks growth momentum. The Piotroski F-Score of 4/9 indicates a stable but non-improving financial health, while the current price ($41.46) sits almost exactly at the Graham Number ($42.65), suggesting defensive fair value. However, the significant gap between the current price and the growth-based intrinsic value ($19.18), combined with negative revenue growth (-9.30%) and bearish insider activity, suggests the stock is priced for a recovery that has not yet materialized in the data.

KRO exhibits severe financial weakness, anchored by a Piotroski F-Score of 2/9, indicating poor operational health and deteriorating fundamentals. The company transitioned from a profit in 2024 to a net loss of $110.9 million in 2025, driven by the cyclical downturn in the TiO2 market and unabsorbed fixed costs. Despite a low Price-to-Sales ratio and a strong current ratio, the company is plagued by negative profit margins and a consistent track record of missing earnings estimates (0/4 beats in the last year). With the current price of $7.21 trading significantly above the analyst target of $5.50, the risk-reward profile is unfavorable.